SecBot SecBot
Insider Cluster (3 insiders) ·Filed Jun 30, 2026

DYN

Dyne Therapeutics, Inc.
NEUTRAL
Impact 5/10
Horizondays Processed4mo ago
Insider cluster: 3 insiders, $5.0M total
Actionable Insight • Neutral

Insider selling is not extreme, but the cluster near a debt facility expansion warrants monitoring. Watch for any upcoming disclosure on clinical data or additional financing that might have motivated these sales. If selling continues, it could pressure shares near term.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$21.79
T+0 close · Jun 30, 2026 · via day close
Latest settled
−24.23%
T+60 · $16.51
Vs SPY
−27.10%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 1 $21.79entry
  2. T+1 · 5mo ago +5.87%α +6.01% · $23.07
  3. T+5 · 4mo ago +9.36%α +9.10% · $23.83
  4. T+20 · 4mo ago +15.19%α +17.38% · $25.10
  5. T+60 · 8w ago −24.23%α −27.10% · $16.51
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three Dyne Therapeutics insiders sold a combined $5.02M in shares over a 6-day window, led by Director Rhodes ($4.9M). CFO Lucera sold a small amount ($48K). The sales follow a recent $50M borrowing under an expanded $400M Hercules debt facility (8-K on 6/17). Total selling represents ~0.14% of market cap, a modest amount that is not alarming given the pre-revenue biotech context.

Key Financial Metrics

Direction
selling
Total Value
$5.0M
Insiders
3

Key Facts

  • Insider cluster: 3 insiders sold 5 trades totaling $5.02M from June 23-29.
  • Director Jason Rhodes sold $5.0M (bulk of sales); CFO Erick Lucera sold $48K.
  • Sales follow June 17 debt facility expansion ($50M draw, $400M total capacity).
  • Total sales represent ~0.14% of DYN's $3.5B market cap.

Financial Impact

Insider sales of $5.02M, modest relative to $3.5B market cap.

dilution

Risk Factors

  • Continued insider selling could signal lack of confidence or pre-arranged plans.
  • Debt facility increases leverage and secured IP collateral; adverse clinical data could trigger covenant issues.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-DYN-1782860743423

Track record

54 reports on DYN

Performance horizon

12 of 16 bullish or bearish reports moved the stock their way by T+20. Best: +46.36% at T+60 after the May 20, 2026 report. 15 of 16 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $16.77 Now $16.70 −0.39% settles Dec 15
  2. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  3. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  4. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  5. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $17.36 Now $16.70 −3.80% settles Dec 4
  6. Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $17.04 Now $16.70 −2.00% settles Nov 27
  7. Oct 22, 202625d ago Press Release Neutral 2/10 Entry $15.62 Now $16.70 +6.91% settles Nov 20
  8. Oct 12, 20265w ago Institutional Cluster Mixed 4/10 Entry $15.96 to $18.62 Now $16.70 +4.64% ▲ +16.67% +19.93% vs SPY
  9. Sep 29, 20266w ago Press Release Bullish 7/10 Entry $16.11 to $16.94 Now $16.70 +3.66% ▲ +5.15% +4.23% vs SPY
  10. Sep 8, 20269w ago Insider Cluster Neutral 3/10 Entry $19.19 to $15.97 Now $16.70 −12.98% ▼ −16.78% −18.72% vs SPY
Showing 10 of 54

US Market Status

Market Closed · Opens Wed (11h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 30, 2026